SPY319.34+7.98 2.56%
DIA271.54+8.21 3.12%
IXIC9,814.08+198.27 2.06%

H.C. Wainwright Reiterates Buy on Crinetics Pharmaceuticals, Lowers Price Target to $30

H.C. Wainwright reiterates Crinetics Pharmaceuticals (NASDAQ:CRNX) with a Buy and lowers the price target from $35 to $30.

Benzinga · 05/22/2020 12:57

H.C. Wainwright reiterates Crinetics Pharmaceuticals (NASDAQ:CRNX) with a Buy and lowers the price target from $35 to $30.